Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
03/2004
03/31/2004EP1401830A2 Quinazolinediones as antibacterial agents
03/31/2004EP1401824A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
03/31/2004EP1401817A1 Isoquinoline compounds having antiinfective activity
03/31/2004EP1401445A1 Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
03/31/2004EP1401443A1 Novel anti-infectives
03/31/2004EP1401431A2 Human growth hormone antagonists
03/31/2004EP1401409A2 Stable powder inhalation dosage formulation
03/31/2004EP1181294B1 Novel derivatives and analogues of galanthamin
03/31/2004EP0808316B1 Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines
03/31/2004CN1486321A Indole derivative and its medicine application
03/31/2004CN1486320A Inhibitors of cruzipain and other cysteine proteases
03/31/2004CN1486312A Pyrazole compounds useful as protein kinase inhibitors
03/31/2004CN1486311A Pyrazole compounds useful as protein kinase inhibitors
03/31/2004CN1486310A Pyrazole compounds useful as protein kinase inhibitors
03/31/2004CN1143859C Camptothecin derivative and its preparation
03/30/2004US6713622 Contacting a 4,7-dichlororhodamine dye comprising a linking group with a polynucleotide comprising a terminal functionality complementary to the linking group
03/30/2004US6713499 Adenosine receptor agonist
03/30/2004US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
03/30/2004US6713484 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
03/30/2004US6713471 Such as tert-butyl-1-methyl-6,7,9,12-tetrahydro-5h-pyrido-(4,3-b)(1,4) thiazepino(2,3,4-hi)indole-11(10h)-carboxylate; serotonin agonists and antagonists; central nervous system disorders
03/30/2004US6713146 Singly recordable compact disc (cd-r)
03/30/2004CA2217499C Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
03/30/2004CA2079706C Inhibitor of atherosclerotic intimal thickening
03/25/2004WO2004024734A1 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
03/25/2004WO2004024733A1 Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
03/25/2004WO2004024732A1 Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans
03/25/2004WO2004024731A1 Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans
03/25/2004WO2004024730A1 Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
03/25/2004WO2004024721A1 Hydantoin derivatives und deren verwendung als tace inhibitoren
03/25/2004WO2004024715A1 Sulphonamide derivatives and their use as tace inhibitors
03/25/2004WO2004024699A1 Benzimidazolones and their use as cytokine inhibitors
03/25/2004WO2004024693A1 Heterocyclic compound having hiv integrase inhibitory activity
03/25/2004WO2003090680A3 Novel phenyl derivatives as inducers of apoptosis
03/25/2004WO2003086306B1 5ht2c receptor modulators
03/25/2004WO2003068765A3 Improved process for the production of dihydropyridines
03/25/2004US20040058969 React with tubulin; forming microtubes; stabilization; antitumor, anticancer agents; antiinflammatory agnets; psoriasis; antiarthritic agents
03/25/2004US20040058953 Antidepressants; obsessive-complusive disorders; eating disorders; sleep disorders; dietetics; drug abuse
03/25/2004US20040058944 Osteoporosis; antiarthritic agents; antidiabetic agents
03/25/2004US20040058931 Potassium channel inhibitors and method
03/25/2004US20040058818 System for increasing the production of camptothecin from plants
03/25/2004CA2498532A1 Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
03/25/2004CA2498134A1 Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
03/25/2004CA2498131A1 Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans
03/25/2004CA2497783A1 Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans
03/25/2004CA2497571A1 Hydantoin derivatives and their use as tace inhibitors
03/25/2004CA2497214A1 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
03/24/2004EP1400523A2 Intermediate compounds
03/24/2004EP1400519A1 Respiratory syncytial virus replication inhibitors
03/24/2004EP1399455A2 Novel tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
03/24/2004EP1399444A2 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
03/24/2004EP1399443A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
03/24/2004EP1399441A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists
03/24/2004EP1399432A1 Spiropiperidine compounds as ligands for orl-1 receptor
03/24/2004EP1399424A1 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide
03/24/2004EP1399105A2 Method for cleaning hard gelatine capsules
03/24/2004EP0777670B1 Substituted camptothecin derivatives and process for their preparation
03/24/2004CN1484643A Hetaryl substituted homotetramic and homotetramic acids and the use thereof as pesticides
03/24/2004CN1484640A Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists
03/24/2004CN1142923C 12,13-modified epothilone derivatives
03/24/2004CN1142918C Carboxylic acid derivs, their preparation and their use
03/24/2004CN1142914C New phenanthridines
03/23/2004US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
03/23/2004US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
03/18/2004WO2004022554A1 Quinazolinone derivatives
03/18/2004WO2004022542A2 Substituted 1,2,3,4-tetrahydroquinoline derivatives
03/18/2004WO2004022537A2 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
03/18/2004WO2003106653A3 Recombinant polynucleotides encoding pro-geldanamycin producing polyketide synthases and accessory proteins, and uses thereof
03/18/2004WO2003020698A3 Protein tyrosine kinase inhibitors
03/18/2004US20040054187 Therapeutic ureas
03/18/2004US20040054177 Novel benzimidazole derivatives
03/18/2004US20040054173 Antiinflammatory agents; autoimmune disease; antiarthritic agents
03/18/2004US20040053996 Use of oxabicyclo[2.2.1]heptane derivatives as pesticidal agents
03/18/2004US20040053987 Bis-heterocyclic compounds with antitumour and chemosensitising activity
03/18/2004US20040053976 Terminally-branched polymeric linkers and polymeric conjugates containing the same
03/18/2004US20040053955 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
03/18/2004US20040053923 Novel isoindole derivatives
03/18/2004US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
03/17/2004EP1398316A2 Process for the preparation of 1,3-Dihydro-6-methylfuro(3,4-c)pyridin-7-ol Derivatives
03/17/2004EP1397366A1 Novel ligand for nicotinic acetylcholine receptors useful in therapy
03/17/2004EP1397361A1 Carboline derivatives as pdev inhibitors
03/17/2004EP1397142A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7
03/17/2004EP1397137A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
03/17/2004EP1047695B1 Novel bispidine antiarrhythmic compounds
03/17/2004EP0925301B1 Highly lipophilic camptothecin derivatives
03/17/2004CN1483024A Vla-4 inhibitors
03/17/2004CN1482129A Process for promoting generation of 10-hydroxycamptothecin in the bud of camptotheca seed
03/17/2004CN1482128A 7-esterified and 7,20-double esterified camptothecine derivant and method for preparing the same and pharmaceutical combination and uses thereof
03/17/2004CN1142174C Optical information gene material and its application in gene chip technology
03/17/2004CN1142164C Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substituent causing optical activity and process for preparing thereof
03/16/2004US6706878 Spiroazabicyclic heterocyclic compounds
03/16/2004US6706717 Thiazolyl inhibitors of Tec family tyrosine kinases
03/16/2004US6706707 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
03/11/2004WO2003096782A3 Process for preparing maytansinol
03/11/2004WO2003091264A3 Non nucleoside reverse transcriptase inhibitors
03/11/2004WO2003018559A3 Intermediates and preparation thereof for the enantioselective synthesis of (20r) homocamptothecins
03/11/2004WO2002076404A3 Fatty alcohol drug conjugates
03/11/2004US20040049043 N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization
03/11/2004US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
03/11/2004US20040049031 Method for the synthesis of quinoline derivatives
03/11/2004US20040048884 3-aminoalkyluracil derivatives, e.g., 1-(2,6-Difluorobenzyl)-5-(3-methoxyphenyl)-6-methyl-3-(N-methyl-N-(2 -pyridylethyl)-aminoethyl)uracil; contraceptives; treating lupus, sex hormone related cancer, benign prostatic hypertrophy, etc.